Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 3/20 | 0.51 |
| ▸ | ADRA2B known ✓ | P18089 | 3/20 | 0.51 |
| ▸ | ADRA2C known ✓ | P18825 | 3/20 | 0.51 |
| ▸ | ADRA1A known ✓ | P35348 | 3/20 | 0.51 |
| ▸ | HTR1A known ✓ | P08908 | 2/20 | 0.51 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
| ▸ | CASR | P41180 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900644 | 0.86 | ADRA2A (0.53) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL7886328 | 0.86 | ADRA2A (0.53) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL900661 | 0.86 | ADRA2A (0.55) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| Hydrochloric Acid SCHEMBL900773 | 0.85 | ADRA2A (0.52) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL2899691 | 0.85 | MAPT (0.55) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| Hydrochloric Acid SCHEMBL3422321 | 0.85 | ADRA2A (0.54) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL7292193 | 0.85 | ADRA2A (0.50) | ADRA2AADRA2BADRA2CADRA1AKDM4E | |
| SCHEMBL2902371 | 0.83 | KDM4E (0.51) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| Hydrochloric Acid SCHEMBL11357932 | 0.82 | KDM4E (0.54) | ADRA2AADRA2BADRA2CADRA1AHTR1A | |
| SCHEMBL11353783 | 0.79 | ENPP2 (0.52) | ADRA2AADRA2BADRA2CADRA1AHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808313-B1 | ANTIPSYCHOTIC 4-(1H-INDOLYL-1-YL)-1-SUBSTITUTED PIPERIDINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2003-08-13 | — | — | EP | disclosed |
| US-5919788-A | PSYCHOLOGICAL DISORDERS | JANSSEN PHARMACEUTICA, N.V. (BE) | 1999-07-06 | — | — | US | disclosed |
| EP-0808313-A1 | ANTIPSYCHOTIC 4-(1H-INDOLYL-1-YL)-1-SUBSTITUTED PIPERIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996023784-A1 | ANTIPSYCHOTIC 4-(1H-INDOLYL-1-YL)-1-SUBSTITUTED PIPERIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-08-08 | — | — | WO | disclosed |